
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Pivotal has announced the acquisition of Akcelis BVBA. Akcelis will bring experience to Pivotal to recruit and retain a patient population for difficult- trials.
For more information, click






